Dokter Konsultasi Daring dengan Dokter Onkologi di Luar Negeri — Halaman 4

Dokter bertanggung jawab atas manajemen keganasan toraks dan mengawasi uji coba kanker toraks di Departemen Onkologi. Penelitian mereka berfokus pada optimalisasi kemoterapi pada penyakit tahap awal, evaluasi terapi baru, eksplorasi pendekatan farmakogenomik, integrasi imunoterapi untuk kanker paru-paru, dan penyelidikan mekanisme resistensi terhadap inhibitor tirosin-kinase.<\/p>

Memegang gelar medis dan PhD dalam onkologi medis dari UAB, dokter ini adalah anggota dari beberapa masyarakat onkologi bergengsi, termasuk ESMO, ASCO, dan IASLC. Mereka telah menerbitkan banyak artikel yang ditinjau sejawat dan bab buku tentang keganasan toraks dan telah memegang posisi pengajaran di UAB dan UVicc-UCC.<\/p>

Dr. Ali Ihsan Anadolulu is a surgical specialist at Central Hospital in Istanbul. He focuses on pediatric gastrointestinal surgery and anorectal malformations. Dr. Anadolulu treats complex colorectal and pelvic floor disorders in children. He uses minimally invasive techniques for pediatric surgical cases.

• Performs specialized surgeries for nephroblastoma and rhabdomyosarcoma removal.
• Treats motility disorders and anorectal malformations in pediatric patients.
• Expert in pituitary tumor surgery for children and adolescents.
• Works at Central Hospital, which features modern neonatal intensive care units.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.

• Highly proficient in IMRT, VMAT, and SBRT for lung and esophageal cancers.
• Former President of Jilin Provincial Cancer Hospital.
• Awarded the National Famous Doctor honor for outstanding contributions to oncology.
• Holds leadership roles in the Chinese Anti-Cancer Association particle therapy committee.

Dokter adalah seorang Onkolog Medis dan Radioterapis dengan pengalaman 33 tahun, yang mengkhususkan diri dalam Onkologi dan Radioterapi. Mereka lulus dari Rumah Sakit Universitas Hadassah di Yerusalem, Israel, dan memiliki kualifikasi dalam Onkologi dan Radioterapi.<\/p>

Saat ini menjabat sebagai Kepala Pusat Kanker Gastrointestinal, dokter juga merupakan Dokter Senior di Departemen Onkologi di Rumah Sakit Universitas Hadassah. Mereka telah menyelesaikan ujian dewan dalam Onkologi dan Radioterapi, dan merupakan anggota dari beberapa masyarakat profesional, termasuk Masyarakat Onkologi Klinis Israel dan Asosiasi Kanker Israel.<\/p>

Dokter menerima pendidikan kedokteran tinggi di Universitas Ibrani dan menyelesaikan residensi dalam bidang penyakit dalam dan gastroenterologi di Rumah Sakit Universitas Hadassah. Magang dalam penyakit hati diselesaikan di Sekolah Kedokteran Sinai di New York. Dokter adalah spesialis dalam pengobatan penyakit hati, memimpin unit penyakit hati di Pusat Medis Hadassah. Mereka adalah anggota dari beberapa asosiasi studi hati internasional dan dewan editorial Clinical Science. Dokter telah menulis banyak artikel dan menerima berbagai penghargaan, termasuk Hadassah Prize dan penghargaan dari Asosiasi Gastroenterologi dan Hepatologi Israel.<\/p>

Dr. Abraham Avigdor is the Director of the Institute of Hematology at Sheba Medical Center. He is a global authority on lymphoma, CAR-T therapy, and complex blood cancers. Dr. Avigdor founded the Israeli Lymphoma Working Group. He helps lead a clinic ranked 7th worldwide by Newsweek in 2026.

• Authored over 130 scientific publications on hemato-oncology and cellular therapy.
• Pioneered the integration of CAR-T cell therapy for lymphoma and myeloma.
• Leads allogeneic and autologous bone marrow transplantation programs.
• Served as the Chairman of the Israeli Lymphoma Study Group.

Dr. Jair Bar is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He specializes in treating advanced non-small cell lung cancer using personalized immunotherapy and targeted treatments. Dr. Bar holds a PhD in Molecular Biology and leads a research lab focused on immunotherapy resistance.

• Chair of the Israel Lung Cancer Group.
• Board-certified in both Medical Oncology and Radiotherapy Oncology.
• Treats patients at Sheba Medical Center, a top-10 globally ranked hospital.
• Uses molecular and genetic profiling to create precise cancer treatment plans.

Dr. Emad Shash is a medical oncologist who has participated in over 70 oncology clinical trials. He serves as the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. Dr. Shash specializes in systemic therapies, including chemotherapy, targeted therapy, and immunotherapy. He holds a Diploma in Hospital Quality Management and Patient Safety from JCI.

• Serves as an ESMO panel voting member and an ASCO committee member.
• Treats breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers.
• Former research physician and medical lead at the EORTC in Brussels.
• Works at Shefaa Al Orman, an ESMO-accredited oncology center treating 6,000 patients annually.

Dr. Amr Mahmoud Al Demery is a consultant thoracic surgical oncologist at Shefaa Al Orman Hospital. He specializes in the diagnosis and surgical treatment of thoracic cancers. Dr. Al Demery is a Member of the Royal College of Surgeons of England. He holds a Doctorate in Surgical Oncology from the National Cancer Institute.

• Cofounder and member of the Egyptian Society of Respiratory Neoplasms.
• Performs complex lung resections, including lobectomy and pneumonectomy.
• Expert in esophageal cancer surgery and chest wall reconstruction.
• Works at an ESMO-accredited center treating 6,000 patients annually.

Dr. Iris Kventsel is a pediatric hemato-oncologist and bone marrow transplant specialist at Sheba Medical Center. She treats childhood sarcomas like Ewing sarcoma and osteosarcoma at the Edmond and Lily Safra Children’s Hospital. Dr. Kventsel integrates targeted therapies with cellular treatments for complex childhood cancers. She serves on the academic staff at Tel Aviv University Faculty of Medicine.

• Specializes in bone marrow transplantation and CAR T-cell therapy for pediatric patients.
• Researches genetic cancer predisposition, including Li-Fraumeni syndrome and susceptibility genes.
• Published in major journals on stem cell biology and surgical oncology (HIPEC).
• Works at Sheba Medical Center, ranked among the world’s top 10 hospitals.

Dokter ini mengkhususkan diri dalam limfoma dan leukemia limfositik kronis, memimpin inovasi dalam analisis dan pengobatan penyakit hematologi. Dikenal secara global atas keahliannya dalam Leukemia Limfositik Kronis (CLL), dokter ini melakukan penelitian klinis dan dasar yang signifikan, berfokus pada patogenesis molekuler dan pendekatan terapeutik baru.<\/p>

Saat ini terlibat dalam lebih dari 80 studi dari fase 1 hingga fase 3, dokter ini berkontribusi pada pengembangan obat dan perawatan baru. Sebagai Kepala Hematologi di IOB Institute of Oncology dan Kepala Departemen Hematologi di Vall d’Hebron University Hospital, dokter ini telah menerbitkan lebih dari 100 artikel di jurnal bergengsi.<\/p>

Dr. Nir Kleinmann directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is a pioneer in kidney-sparing laser surgery for complex tumors. Forbes and ResultMed named him among Israel’s Best Doctors for 2025 and 2026. Dr. Kleinmann uses a unique dual-laser system to preserve organ function during cancer treatment.

• Completed urological fellowships at Thomas Jefferson University and McMaster University.
• Expert in minimally invasive treatments for UTUC, kidney stones, and prostate cancer.
• Served as a researcher in the OLYMPUS trial for non-surgical chemoablation.
• Fellow of the American Endourology Society with over 60 scientific publications.

Dokter ini berspesialisasi dalam angiogenesis, mekanisme perbaikan DNA, dan imunologi, berperan sebagai Peneliti Utama dalam uji klinis untuk kanker ovarium, serviks, dan endometrium. Dengan gelar dalam bidang Kedokteran dan Bedah dari Universitas Complutense Madrid dan gelar PhD dari Universidad Autonoma de Barcelona, dokter ini telah menerbitkan lebih dari 100 karya dan presentasi. Dokter ini adalah Co-Ketua Grup GEICO dan anggota fakultas untuk Gyn-Track di European Society of Medical Oncology. Selain itu, dokter ini adalah anggota aktif ASCO, ESMO, dan SEOM.<\/p>

Dokter ini mengkhususkan diri dalam pengobatan kanker payudara dan endokrin, dengan fokus pada mengatasi resistensi terhadap terapi hormon selama penyakit adjuvan dan metastatik. Secara aktif terlibat dalam studi fase 1, 2, dan 3 untuk kanker payudara dan melanoma, dokter ini telah berkontribusi pada persetujuan obat baru, termasuk inhibitor cdk4/6 seperti palbociclib dan ribociclib untuk kanker payudara metastatik, dan perawatan imunoterapi seperti Pembrolizumab, Nivolumab, dan Ipilimumab untuk melanoma. Dokter ini adalah anggota dari Unit Kanker Payudara dan Unit Melanoma di Rumah Sakit Universitas Vall d’Hebron dan Institut Onkologi Vall d’Hebron.<\/p>

Dokter adalah seorang ilmuwan klinis dengan keahlian dalam penerapan klinis dari temuan laboratorium pada kanker payudara, berfokus pada ekspresi gen dan subtipe molekuler. Dokter merancang dan memimpin uji klinis untuk obat dan pendekatan baru di SOLTI, sebuah kelompok koperasi kanker payudara Spanyol.<\/p>

Setelah lulus dengan gelar MD dari Universitas Barcelona pada tahun 2003, dokter menyelesaikan fellowship onkologi medis di Institut Onkologi Vall d'Hebron dan penelitian pascadoktoral di Universitas Carolina Utara.<\/p>

Saat ini, dokter memimpin Kelompok Genomik Translasional dan Terapi Bertarget pada Tumor Padat di IDIBAPS dan merupakan Presiden Dewan Direksi SOLTI. Dokter telah ikut mendirikan Reveal Genomics dan memegang tiga paten.<\/p>

Dengan lebih dari 160 publikasi dan H-Index 51, dokter telah dikutip 13.479 kali dan telah menyampaikan 95 komunikasi secara internasional.<\/p>

Dr. Beni Boursi is a leading oncologist at Sheba Medical Center. He founded the ECOG-ACRIN Microbiome Working Group. He specializes in treating gastrointestinal cancers using innovative microbial modulation. Dr. Boursi is board certified in internal medicine and medical oncology. He earned his medical degree with highest honors from Tel Aviv University.

• Completed oncology fellowships at the University of Pennsylvania.
• Trained in medical oncology at MD Anderson and Mayo Clinic.
• Developed predictive models for early colorectal and pancreatic cancer diagnosis.
• Published research on microbiome-oncology in the prestigious journal Science.

Dr. Raanan Berger is the Director of the Cancer Center at Sheba Medical Center. He was listed in Forbes Israel’s “Best Doctors” in 2025. Dr. Berger specializes in genitourinary oncology and radiates complex prostate tumors. He completed a postdoctoral fellowship at the Dana-Farber/Harvard Cancer Institute.

• Heads the clinical research unit focusing on molecular oncology.
• Co-authored over 20 peer-reviewed papers on prostate cancer and BRCA mutations.
• Member of the American Society of Clinical Oncology (ASCO).
• Performs systemic therapy and radiotherapy at a Top-10 globally ranked hospital.